Long QT syndrome - Symptoms, Causes, Treatment & Prevention

📅 Updated: April 2026 ⏱️ 6 min read ✅ Medically reviewed
```html Long QT Syndrome – Comprehensive Medical Guide

Overview

Long QT syndrome (LQTS) is a disorder of the heart’s electrical system that prolongs the time it takes for the heart’s ventricles to recharge between beats. This is reflected on an electrocardiogram (ECG) as an abnormally long QT interval. The condition can be inherited (congenital) or acquired through medications, electrolyte disturbances, or other medical conditions.

Both men and women can be affected, but women are about 1.5‑2 times more likely to experience symptoms after puberty. The estimated prevalence of congenital LQTS is roughly 1 in 2,000–2,500 people worldwide, making it one of the more common inherited arrhythmia syndromes.1 Acquired LQTS is more common, especially in patients taking QT‑prolonging drugs or those with severe electrolyte abnormalities.

Symptoms

Many people with LQTS are asymptomatic until a triggering event occurs. When symptoms appear, they are usually related to abnormal heart rhythms (ventricular tachycardia or torsades de pointes). Common manifestations include:

  • Syncope (fainting): Often occurs during sudden exertion, emotional stress, or after a loud noise. The loss of consciousness is usually brief, lasting seconds.
  • Palpitations: A sensation of “skipping” or “fluttering” beats, sometimes felt before a syncopal episode.
  • Seizure‑like activity: Brief convulsions can accompany a sudden drop in cerebral perfusion during a prolonged arrhythmia.
  • Sudden cardiac arrest (SCA): The most serious presentation; the heart stops pumping effectively, leading to loss of consciousness and, if not treated promptly, death.
  • Exercise‑induced symptoms: Swimming, running, or competitive sports can precipitate episodes in certain LQTS sub‑types.
  • Loud‑noise triggered events: Sudden auditory stimuli (e.g., alarm clocks, telephone ring) may trigger arrhythmias in LQT2.
  • Chest discomfort or shortness of breath: Less common, but may accompany a rapid heart rhythm.

Approximately 30‑40% of individuals with congenital LQTS will experience at least one syncopal episode before the age of 20.2

Causes and Risk Factors

Congenital (Inherited) LQTS

Mutations in genes that encode cardiac ion channels disrupt the flow of potassium or sodium ions, lengthening repolarization. The three most common genetic forms are:

  • LQT1: Mutations in the KCNQ1 gene (potassium channel). Triggered mainly by exercise, especially swimming.
  • LQT2: Mutations in the KCNH2 (HERG) gene (potassium channel). Triggered by auditory stress.
  • LQT3: Mutations in the SCN5A gene (sodium channel). Often associated with events during rest or sleep.

Over 17 genes have been implicated, accounting for ~75% of diagnosed cases.3

Acquired LQTS

Factors that lengthen the QT interval in people without a genetic predisposition include:

  • Medications: Certain antiarrhythmics (e.g., sotalol), antibiotics (e.g., macrolides, fluoroquinolones), antipsychotics, antidepressants, and anti‑emetics.
  • Electrolyte abnormalities: Low potassium (hypokalemia), low magnesium (hypomagnesemia), or low calcium (hypocalcemia).
  • Medical conditions: Myocardial infarction, severe bradycardia, heart failure, and central nervous system disorders.
  • Substance use: Excessive alcohol, recreational drugs (e.g., cocaine), and certain herbal supplements.

Risk Factors

  • Family history of syncope, sudden cardiac death, or known LQTS.
  • Female sex (higher risk of symptomatic events after puberty).
  • Use of QT‑prolonging drugs without proper monitoring.
  • Electrolyte disturbances, especially in hospital settings.
  • Pre‑existing heart disease that alters repolarization.

Diagnosis

Diagnosing LQTS requires a combination of clinical evaluation, ECG findings, and often genetic testing.

Electrocardiogram (ECG)

  • QTc measurement: The corrected QT interval (QTc) accounts for heart rate. A QTc ≥ 460 ms in women or ≥ 450 ms in men is generally considered prolonged, but values ≥ 500 ms carry a high risk of torsades de pointes.
  • Morphology clues: Specific patterns (e.g., bifid T‑waves in LQT1) may hint at the underlying genotype.

Clinical Scoring Systems

The Schwartz score* combines ECG findings, personal/family history, and symptoms to estimate the probability of congenital LQTS. A score ≥ 3.5 suggests a high likelihood.

Holter Monitoring / Event Recorders

Continuous or intermittent recording helps capture intermittent QT prolongation or arrhythmias not seen on a standard ECG.

Exercise Stress Testing

Observes QTc dynamics during exertion; in LQT1, the QT interval fails to shorten appropriately.

Genetic Testing

Panel testing for known LQTS genes is recommended when the clinical suspicion is high, especially for family screening. Identification of a pathogenic variant confirms the diagnosis and guides therapy.

Laboratory Tests

Serum electrolytes, magnesium, calcium, and drug levels are evaluated to rule out or treat acquired causes.

Treatment Options

Management aims to prevent life‑threatening arrhythmias while allowing patients to lead as normal a life as possible.

Medications

  • Beta‑blockers: First‑line therapy (e.g., nadolol, propranolol). They blunt the adrenergic surge that can precipitate torsades, especially effective in LQT1.
  • Mexiletine: A class IB anti‑arrhythmic that shortens QTc in LQT3 patients.
  • Potassium supplements or potassium‑sparing agents: Helpful in acquired LQTS with hypokalemia.
  • ICD (Implantable Cardioverter‑Defibrillator): Reserved for patients with documented cardiac arrest, refractory syncope despite medication, or very high‑risk genotypes.

Procedures

    left{
  • Left Cardiac Sympathetic Denervation (LCSD): Surgical removal of sympathetic nerves to the heart. Reduces adrenergic triggers, beneficial for patients intolerant to beta‑blockers or with recurrent events.

Lifestyle & Activity Modifications

  • Avoid competitive sports or high‑intensity endurance activities (especially swimming) unless cleared after careful evaluation.
  • Maintain stable electrolyte levels – regular blood tests if on diuretics or have gastrointestinal losses.
  • Review all medications with a pharmacist or physician; use online databases (e.g., CredibleMeds) to check QT‑prolonging potential.
  • Educate family members about the importance of immediate CPR and AED use.

Living with Long QT Syndrome

With appropriate treatment, most individuals can lead active lives. Practical tips include:

  • Medication adherence: Set daily reminders; keep a medication list handy for every healthcare encounter.
  • Regular follow‑up: Cardiology visits every 6–12 months, with ECG or Holter to monitor QTc.
  • Genetic counseling: First‑degree relatives should be screened, even if asymptomatic.
  • Personal emergency plan: Carry a card or medical bracelet stating “Long QT Syndrome – beta‑blocker therapy – avoid certain drugs.”
  • Physical activity: Low‑to‑moderate aerobic exercise (e.g., walking, stationary cycling) is usually safe; obtain cardiology clearance before starting new programs.
  • Stress management: Techniques such as yoga, mindfulness, and controlled breathing can reduce sudden sympathetic surges.

Prevention

While congenital LQTS cannot be prevented, the risk of arrhythmic events can be markedly reduced:

  • Screen high‑risk families (e.g., sudden cardiac death in a first‑degree relative) with ECG and genetic testing.
  • In hospital settings, monitor QT interval when initiating known QT‑prolonging drugs.
  • Correct electrolyte imbalances promptly, especially in patients on diuretics or with vomiting/diarrhea.
  • Avoid excessive alcohol and illicit stimulants.
  • Educate patients on safe medication use; pharmacists play a key role.

Complications

If left untreated or inadequately managed, LQTS can lead to serious outcomes:

  • Syncope injuries: Falls during fainting episodes may cause fractures or head trauma.
  • Sudden cardiac death (SCD): Estimated annual risk of SCD ranges from 2% to 5% in untreated high‑risk patients.4
  • Psychological impact: Anxiety or depression due to activity restrictions or fear of sudden events.
  • Medication side‑effects: Over‑dosage of beta‑blockers can cause bradycardia, fatigue, or bronchospasm in asthmatics.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department immediately if you experience:
  • Sudden loss of consciousness (even brief) without an obvious cause.
  • Palpitations accompanied by dizziness, chest pain, or shortness of breath.
  • Seizure‑like activity without a known seizure disorder.
  • Rapid, irregular heartbeats that feel “fluttering” or “jumping.”
  • Any cardiac arrest symptoms (no pulse, no breathing) – start CPR and use an AED if available.
Prompt treatment with defibrillation and anti‑arrhythmic therapy can be lifesaving.

References:

  1. Mayo Clinic. “Long QT Syndrome.” Updated 2023. https://www.mayoclinic.org
  2. Antzelevitch C, et al. “Long QT syndrome: from genetics to management.” Nat Rev Cardiol. 2022;19:152‑168.
  3. National Heart, Lung, and Blood Institute (NHLBI). “Genetic Testing for Inherited Cardiac Arrhythmias.” 2021.
  4. Goldenberg I, Moss AJ. “Sudden cardiac death in the young.” Cardiovasc Res. 2020;116(2):312‑321.
  5. CredibleMeds. “List of QT‑Prolonging Drugs.” Accessed 2024. https://www.crediblemeds.org
```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References